These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9198062)

  • 1. Severe hyperkalaemia after cotrimoxazole administration in a patient with hyporeninaemic hypoaldosteronism.
    Elisaf M; Terrovitou C; Tomos P; Siamopoulos KC
    Nephrol Dial Transplant; 1997 Jun; 12(6):1254-5. PubMed ID: 9198062
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible voltage-dependent distal renal tubular acidosis in a patient receiving standard doses of trimethoprim-sulphamethoxazole.
    Lin SH; Kuo AA; Yu FC; Lin YF
    Nephrol Dial Transplant; 1997 May; 12(5):1031-3. PubMed ID: 9175064
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study.
    Crellin E; Mansfield KE; Leyrat C; Nitsch D; Douglas IJ; Root A; Williamson E; Smeeth L; Tomlinson LA
    BMJ; 2018 Feb; 360():k341. PubMed ID: 29438980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotrimoxazole-induced hyperkalaemia in a patient with known hypoaldosteronism.
    Montebello A; Gruppetta M
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33664032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-induced exacerbation of hyperkalemia in a dog with hypoadrenocorticism.
    Rubin SI; Toolan L; Halperin ML
    J Vet Intern Med; 1998; 12(3):186-8. PubMed ID: 9595382
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe hyperkalemia with trimethoprim-quinapril.
    Thomas RJ
    Ann Pharmacother; 1996 Apr; 30(4):413-4. PubMed ID: 8729901
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.
    Antoniou T; Gomes T; Mamdani MM; Yao Z; Hellings C; Garg AX; Weir MA; Juurlink DN
    BMJ; 2011 Sep; 343():d5228. PubMed ID: 21911446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hyperkalaemia due to mefenamic acid-induced hyporeninaemic hypoaldosteronism.
    Chan JC; Chan TY; Ko TC; Chow CC; Critchley JA
    Br J Clin Pract; 1995; 49(3):161-2. PubMed ID: 7779674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism.
    van Nieuwkoop C; Ijpelaar DH; Bolk JH
    Neth J Med; 2007 Feb; 65(2):75-7. PubMed ID: 17379933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hyperkalaemia.
    Xu B; Murray M
    Aust Fam Physician; 2009 May; 38(5):307-9. PubMed ID: 19458800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.
    Antoniou T; Hollands S; Macdonald EM; Gomes T; Mamdani MM; Juurlink DN;
    CMAJ; 2015 Mar; 187(4):E138-E143. PubMed ID: 25646289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim-sulfamethoxazole associated with hyperkalemia.
    Marinella MA
    West J Med; 1997 Nov; 167(5):356-8. PubMed ID: 9392994
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Trimethoprim-sulfamethoxazole was linked to sudden death in older patients using spironolactone.
    Ananthakrishnan S
    Ann Intern Med; 2015 Jun; 162(12):JC13. PubMed ID: 26075778
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic epidermal necrolysis due to cotrimoxazole.
    Lipozencic J; Milavec-Puretic V; Kotrulja L; Tomicic H; Stulhofer Buzina D
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):182-3. PubMed ID: 12046835
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of urinary tract infection with a single dose of Biseptol].
    Cervenová O; Dzúriková V
    Bratisl Lek Listy; 1988 May; 89(5):340-2. PubMed ID: 3260807
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
    Alappan R; Perazella MA; Buller GK
    Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital admissions for hyperkalemia with trimethoprim-sulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections.
    Lam N; Weir MA; Juurlink DN; Gunraj N; Gomes T; Mamdani M; Hackam DG; Jain AK; Garg AX
    Am J Kidney Dis; 2011 Mar; 57(3):521-3. PubMed ID: 21216514
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Bugge JF
    J Intern Med; 1996 Oct; 240(4):249-51. PubMed ID: 8918517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life threatening hyperkalemia and acidosis secondary to trimethoprim-sulfamethoxazole treatment.
    Margassery S; Bastani B
    J Nephrol; 2001; 14(5):410-4. PubMed ID: 11730276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of co-trimazine once daily and co-trimoxazole twice daily in treatment of urinary tract infections in children.
    Adam D; Hager C; Dorn G; Bamberg P
    J Antimicrob Chemother; 1982 Nov; 10(5):453-8. PubMed ID: 6983524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.